Trial Profile
Co-administration study of linaclotide + proton pump inhibitor for GERD and constipation-predominant IBS or chronic idiopathic constipation
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 07 May 2015
Price :
$35
*
At a glance
- Drugs Linaclotide (Primary) ; Proton pump inhibitors
- Indications Constipation; Gastro-oesophageal reflux; Irritable bowel syndrome
- Focus Therapeutic Use